Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase ii trial

Cancer Prevention Research

Volumn 5, Issue 2, 2012, Pages 309-319

  Khan, Seema A ^a   Chatterton, Robert T ^a   Michel, Nancy ^a   Bryk, Michelle ^a   Lee, Oukseub ^a   Ivancic, David ^a   Heinz, Richard ^a   Zalles, Carola M ^c   Helenowski, Irene B ^a   Jovanovic, Borko D ^a   Franke, Adrian A ^d   Bosland, Maarten C ^b   Wang, Jun ^a   Hansen, Nora M ^a   Bethke, Kevin P ^a   Dew, Alexander ^a   Coomes, Margerie ^a   Bergan, Raymond C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; ISOFLAVONE; KI 67 ANTIGEN; PLACEBO; PTIG 2535; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST; BREAST CANCER; BREAST EPITHELIUM; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; NIPPLE ASPIRATION; PHASE 2 CLINICAL TRIAL; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOYBEAN; SUPPLEMENTATION;

ADULT; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; PROGNOSIS; RISK REDUCTION BEHAVIOR; SOYBEANS;

EID: 84863263259     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0251     Document Type: Article

References (39)

1. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005;97:1652-62. (Pubitemid 41672231)
2. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295:2727-41.
3. Port ER, Montgomery LL, Heerdt AS, Borgen PI. Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 2001;8:580-5. (Pubitemid 32735038)
4. Tchou J, Hou N, Rademaker A, Jordan VC, Morrow M. Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer 2004;100:1800-6. (Pubitemid 38529556)
5. Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, et al. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 2004;100:942-9. (Pubitemid 38222854)
6. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-71.
7. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011;125:315-23.
8. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, et al. Soy food intake and breast cancer survival. JAMA 2009;302:2437-43.
9. Messina M, Hilakivi-Clarke L. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 2009;61:792-8.
10. Allred CD, Ju YH, Allred KF, Chang J, Helferich WG. Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 2001;22: 1667-73. (Pubitemid 32952145)
11. Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, et al. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 2004;25:211-8. (Pubitemid 38239804)
12. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000; 92:1217-27. (Pubitemid 30627730)
13. Mansoor I, Zalles C, Zahid F, Gossage K, Levenson RM, Rimm DL. Fine-needle aspiration of follicular adenoma versus parathyroid adenoma: the utility of multispectral imaging in differentiating lesions with subtle cytomorphologic differences. Cancer 2008;114:22-6. (Pubitemid 351304609)
14. Khan SA, Lankes HA, Patil DB, Bryk M, Hou N, Ivancic D, et al. Ductal lavage is an inefficient method of biomarker measurement in high-risk women. Cancer Prev Res 2009;2:265-73.
15. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990;66: 1480-7. (Pubitemid 20355413)
16. The uniform approach to breast fine-needle aspiration biopsy. NIH Consensus Development Conference. Am J Surg 1997;174: 371-85.
17. Zalles C, Zalles N, Mahooti S, Zahid F, Khan SA, Rimm DL. Objective spectral-spatial analysis of random periareolar fine needle aspiration of women at high risk for contralateral breast cancer. In: Proceedings of the CTRC-AACR San Antonia Breast Cancer Symposium; 2009 Dec 13; San Antonio, TX. Abstract nr 6001.
18. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008;269:226-42.
19. Dip R, Lenz S, Antignac JP, Le BB, Gmuender H, Naegeli H. Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocr Relat Cancer 2008;15:161-73. (Pubitemid 351449736)
20. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-9. (Pubitemid 36576916)
21. Gamache PH, Acworth IN. Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection. Proc Soc Exp Biol Med 1998;217:274-80.
22. Franke AA, Custer LJ. High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B Biomed Appl 1994;662:47-60. (Pubitemid 24376282)
23. Rotti K, Stevens J, Watson D, Longcope C. Estriol concentrations in plasma of normal, non-pregnant women. Steroids 1975;25:807-16.
24. Chatterton RT Jr, Khan SA, Heinz R, Ivancic D, Lee O. Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Cancer Epidemiol Biomarkers Prev 2010;19:275-9.
25. Chatterton RT Jr, Geiger AS, Khan SA, Helenowski IB, Jovanovic BD, Gann PH. Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev 2004; 13:928-35. (Pubitemid 38756702)
26. Maskarinec G, Watts K, Kagihara J, Hebshi SM, Franke AA. Urinary isoflavonoid excretion is similar after consuming soya milk and miso soup in Japanese-American women. Br J Nutr 2008;100:424-9.
27. Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006;136:2188-93. (Pubitemid 44156823)
28. Grubbs FE. Criteria for testing outlying observations. Annals of Mathematical Statistics 1950;21:27-58.
29. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 1995;57:289-300.
30. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 2007; 16:538-45. (Pubitemid 46548658)
31. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999;84:4017-24. (Pubitemid 30648799)
32. Wood CE, Hester JM, Appt SE, Geisinger KR, Cline JM. Estrogen effects on epithelial proliferation and benign proliferative lesions in the postmenopausal primate mammary gland. Lab Invest 2008;88: 938-48.
33. Wood CE, Appt SE, Clarkson TB, Franke AA, Lees CJ, Doerge DR, et al. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Reprod 2006;75:477-86. (Pubitemid 44268082)
34. Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ. Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005;14:786-9. (Pubitemid 40478536)
35. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002; 57:257-75.
36. Plymate SR, Moore DE, Cheng CY, Bardin CW, Southworth MB, Levinski MJ. Sex hormone-binding globulin changes during the menstrual cycle. J Clin Endocrinol Metab 1985;61:993-6. (Pubitemid 16218504)
37. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999;84:3479-84. (Pubitemid 30645194)
38. Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 2009;101:1141-55.
39. Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, et al. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 2009;18: 1050-9.